Skip to content
What we do
Close What we do
Open What we do
Strategic service solutions
Strategic consulting
Medical communications
Commercialization
Revenue management and market access
AI and technology solutions
iEnvision
Insights & Analytics
Envision AI Labs
Riparian technology
About
News and views
Careers
Close Careers
Open Careers
Life at Envision
Benefits at Envision
Open opportunities
FAQs
Meet the talent team
Contact
MENU
MENU
Home
What we do
About
News and views
Careers
Contact
Search
Search
News and
views:
Charity
New
Supporting the blood cancer community, together
Blood cancer
,
Charity
,
Patient Engagement
Oct. 09, 2026
Envision Pharma Group, Two Labs, and Riparian to take part in Light The Night on November 7...
Learn More
Share
The Adaptive Advocacy Impact Framework
Patient Advocacy
,
Patient Engagement
,
Technology
Oct. 08, 2026
From engagement to impact: A decision-focused approach to measuring the value of patient advocacy across the product life cycle...
Learn more
From publications to evidence ecosystems
AI
,
Medical
,
Publications
,
Technology
Oct. 06, 2026
Eight priorities for future-ready publication leaders...
Learn more
Connected evidence: from insight to impact
AI
,
Publications
,
Technology
Sep. 22, 2026
The future of scientific evidence and publications...
Learn more
What actually moves the needle: measuring the value of patient advocacy
Patient Advocacy
,
Patient Engagement
,
Strategic Consulting
Sep. 01, 2026
Learn more
Envision Pharma Group appoints Ryan Tubbs as Senior Vice President, Commercial Growth
Commercialization
,
Executive Leadership
,
Technology
Aug. 25, 2026
New role brings commercial growth and client experience together to support a more connected approach for Envision’s life sciences clients...
Learn more
What actually moves the needle: Redefining patient advocacy impact measures
Medical
,
Patient Engagement
,
Strategic Consulting
Jul. 23, 2026
Sign up to receive the white paper and access the Adaptive Advocacy Impact Framework...
Learn more
Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next
